Healthcare Beyond Barriers
Digipharm brings together industry expertise, a mature concept and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach.
Spiralling healthcare costs combined with resource constraints have resulted in an unremitting burden on health systems. Trade-offs need to be made, patients are at risk of being denied innovative treatments and there remains barriers to reimbursement for manufacturers.
Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data.
Disclaimer
This Whitepaper is provided by Digipharm GmbH for informational purposes only. Nothing in this Whitepaper shall be construed as an offer to sell or buy securities in any jurisdiction, or a solicitation for investment, or an investment advice. The Whitepaper does not regulate any sale and purchase of DPH tokens (as referred to in the Whitepaper). The purchase of DPH tokens is subject to the Token Sale Terms and Conditions and the use of DPH is subject to the Platform Terms and Policies.
This Whitepaper describes the current vision for the DPH platforms. While we intend to attempt to
realize this vision, please recognize that it is dependent on quite a number of factors and subject
to quite a number of risks. It is entirely possible that platforms will never be implemented or
adopted, or that only a portion of our vision will be realized. We do not guarantee or warrant any
of the statements in this Whitepaper, because they are based on our current beliefs, expectations
and assumptions, about which there can be no assurance due to various anticipated and
unanticipated events that may occur. Blockchain, cryptocurrencies and other aspects of the
technology used for the DPH platforms is in its infancy and will be subject to many challenges,
competition and a changing environment. We will try to update our community as things grow
and change, but undertake no obligation to do so. Due to the retrospective nature of regulatory
action or guidance, we can make no guarantees regarding the legality of the DPH platforms or
the DPH token launch in any given jurisdiction. We must operate DPH platforms in accordance
with the laws of relevant jurisdictions. As such, the DPH platforms or DPH tokens may not be
immediately available in certain countries.
DPH tokens are functional utility smart contracts within the DPH platforms. DPH tokens are
non-refundable and are not for speculative investment. No promises of future performance or
value are or will be made with respect to DPH tokens, including no promise of inherent value,
no promise of continuing payments, and no guarantee that DPH tokens will hold any particular
value. DPH tokens are not securities and are not a participation in Digipharm GmbH. DPH tokens
hold no rights in Digipharm GmbH. This Whitepaper may be updated or altered, with the latest
version of the Whitepaper prevailing over previous versions and we are not obliged to give you
any notice of the fact or content of any changes. The latest version of the Whitepaper in English
is available at the website [https://digipharm.ch]. While we make every effort to ensure that all
data submitted in the Whitepaper is accurate and up to date at the point in time that the relevant
version has been disseminated, the proposed Whitepaper is no alternative to consulting an
independent 3rd party opinion.
The Whitepaper does not constitute an agreement that binds Digipharm GmbH. Digipharm
GmbH, Digipharm GmbH’s directors, officers, employees and associates do not warrant or
assume any legal liability arising out of or related to the accuracy, reliability, or completeness
of any material contained in the Whitepaper. To the fullest extent permitted by any applicable
law in any jurisdiction, Digipharm GmbH disclaim all liability to you and everyone else in respect
of the content of this Whitepaper, whether under any theory of tort, contract or otherwise and
whether in respect of direct, indirect, consequential, special, punitive or similar damages.
Persons who intend to purchase DPH tokens, should seek the advice of independent experts
before committing to any action, set out in the Whitepaper.
0 Comments